top of page

Nanotrap® particles pre-concentrate and improve the detection of fentanyl and its analogs

Objective: To develop and demonstrate the utility of a universal Nanotrap® technology solution for improved detection of fentanyl and fentanyl derivatives in urine and oral fluid samples.

Results: 1) Nanotrap® particles improved sensitivity of Neogen’s ELISA for 9 fentanyl analogs. 2) Nanotrap® particles enriched fentanyl analogs from synthetic urine and oral fluid samples.

The protocol used in these experiments is compatible with Thermo DRI assays and LC-MS platforms.

Next Steps: Further studies are planned to establish fentanyl and analog LLODs as well as integration strategies for other analytical platforms.

Impact: Nanotrap® particles can provide universal pre-concentration of multiple fentanyl analogs from a single sample prior to analysis. This pre-concentration approach can expand the utility and performance of existing assays in POC and reference laboratory settings while helping to address the current technical bottlenecks.

Related Posts

See All


bottom of page